Standout Papers

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inh... 2012 2026 2016 2021 806
  1. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer (2012)
    Andrew Weickhardt, Benjamin Scheier et al. Journal of Thoracic Oncology
  2. Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer (2012)
    Robert C. Doebele, Amanda Pilling et al. Clinical Cancer Research

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 87 standout
Sub-graph 1 of 21

Citing Papers

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
4 intermediate papers

Works of Andrew Weickhardt being referenced

Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
2012 Standout
Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer
2011
and 1 more

Author Peers

Author Last Decade Papers Cites
Andrew Weickhardt 2274 2229 256 947 107 3.2k
Vincenzo Adamo 2132 2336 235 988 115 3.7k
Luca Toschi 1894 1892 448 981 95 3.3k
Thomas Brodowicz 1933 2289 342 573 125 3.3k
Mark S. Huberman 3221 2978 207 1195 80 4.4k
V.A. Miller 1596 2049 139 913 83 2.9k
Hong‐Hong Yan 2779 2412 184 840 129 3.6k
Davey B. Daniel 2023 2170 161 524 80 3.2k
Joo Hang Kim 1818 1825 139 775 89 3.0k
Alessandro Russo 1323 1447 223 835 117 2.6k
Tommaso De Pas 2081 2412 207 944 151 4.1k

All Works

Loading papers...

Rankless by CCL
2026